Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CME America is a U.S. medical device company focused on ambulatory infusion systems and related administration sets used for infusion therapy across homecare, acute care, infusion centers, emergency medical services, and medical transport. The company has been described as a wholly owned subsidiary of BD (Becton, Dickinson and Company) and has marketed the BodyGuard and CMExpress infusion product lines in the United States and the Americas. Its business is commercial rather than drug-development oriented, centered on infusion pumps, syringe drivers, and disposable sets rather than therapeutic pipelines. Public sources indicate the company was founded in 2007 and based in Golden, Colorado. Although some CME America products were subject to major FDA recalls and certain BodyGuard products were removed from the U.S. market in 2020, the legal entity appears to remain active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CME America.